The conversation around psychedelics has changed dramatically over the past decade. Once associated almost entirely with counterculture movements and illegal drug use, compounds like psilocybin, MDMA, and ketamine are now entering mainstream clinical discussions. Researchers continue to publish promising results for treatment-resistant depression, PTSD, anxiety, and addiction...
Click on the "Follow" button below and you'll get the latest news from Pharma Marketing Network via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
Pharma Marketing Network title: HOME - Pharma Marketing Network